|
| |
| | | | 1 | | | DO1.PCCNTR.1143524 ContractData Container |
| | | 1.1 | | | | | | | | | | 236,465,497.00 | 0.00 | 0.00 | 0.00 | 236,465,497.00 | 236,465,497.00 |
|
| | | | | | | 1 | | 51201901 - Acetato de gla(...)51201901 - Acetato de glatiramer |
| 2.3.4.1.01 | Daratumumab 400 mg vial | 806 | UD | 100,872 | 100,872 | 81,302,832.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 81,302,832.00 | 81,302,832.00 | |
|
| | | | | | | 2 | | 51201901 - Acetato de gla(...)51201901 - Acetato de glatiramer |
| 2.3.4.1.01 | Golimumab 50 mg/1ml pluma precargada | 570 | UD | 35,096 | 35,096 | 20,004,720.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 20,004,720.00 | 20,004,720.00 | |
|
| | | | | | | 3 | | 51201901 - Acetato de gla(...)51201901 - Acetato de glatiramer |
| 2.3.4.1.01 | Guselkumab 100mg/1ml jeringa precargada | 50 | UD | 96,152 | 96,152 | 4,807,600.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 4,807,600.00 | 4,807,600.00 | |
|
| | | | | | | 4 | | 51201901 - Acetato de gla(...)51201901 - Acetato de glatiramer |
| 2.3.4.1.01 | IBrutinib 140 mg capsula | 18,900 | UD | 4,300 | 4,300 | 81,270,000.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 81,270,000.00 | 81,270,000.00 | |
|
| | | | | | | 6 | | 51201901 - Acetato de gla(...)51201901 - Acetato de glatiramer |
| 2.3.4.1.01 | Lapatinib 250 mg comprimidos | 2,100 | UD | 748.85 | 748.85 | 1,572,585.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 1,572,585.00 | 1,572,585.00 | |
|
| | | | | | | 8 | | 51201901 - Acetato de gla(...)51201901 - Acetato de glatiramer |
| 2.3.4.1.01 | Ustekinumab 45 mg/0.5 ml jeringa precargada | 140 | UD | 154,899 | 154,899 | 21,685,860.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 21,685,860.00 | 21,685,860.00 | |
|
| | | | | | | 9 | | 51201901 - Acetato de gla(...)51201901 - Acetato de glatiramer |
| 2.3.4.1.01 | Ustekinumab 90 mg/1ml jeringa precargada | 90 | UD | 286,910 | 286,910 | 25,821,900.00 | | 0.00 | | 0 | 0.00 | | 0.00 | 25,821,900.00 | 25,821,900.00 | |
|
|
| | | |
| | | |
|